BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 7425449)

  • 1. [Comments about use of polychemotherapy MOPP associated with radiotherapy in the treatment of early stages of Hodgkin's disease. Preliminary report of 58 patients (author's transl)].
    Brun B; Alaoui Y; Kuentz M; Baillet F; Maylin C; Vernant JP; Reyes F; Rochant H; Pierquin B; Dreyfus B
    Ann Med Interne (Paris); 1980; 131(4):239-43. PubMed ID: 7425449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [81 cases of Hodgkin's disease treated with extensive radiotherapy, including 65 with primary MOPP chemiotherapy (author's transl)].
    Baillet F; Brun B; Maylin C; Mazeron JJ; Pierquin B; Dreyfus B
    J Radiol Electrol Med Nucl; 1977 May; 58(5):343-6. PubMed ID: 886528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Results with MOPP combination chemotherapy in Hodgkin's disease (author's transl)].
    Neumann E
    Wien Klin Wochenschr; 1981 Feb; 93(4):134-7. PubMed ID: 6895134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric Hodgkin's disease.
    Oliapuram Jose B; Koerner P; Bertolone S; Patel CC; Spanos WJ; Paris KJ; Silverman CL; Yashar CM
    J Ky Med Assoc; 2004 Mar; 102(3):104-6. PubMed ID: 15067795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chemotherapy-radiotherapy association in the treatment of localized forms of Hodgkin's disease. Prognosis of polychemotherapy after three trials of M.O.P.P].
    Baillet F; Brun B; Mazeron JJ; Rochant H; Pinon G; Reyes F; Vernant JP; Pierquin B; Dreyfus B
    Nouv Rev Fr Hematol Blood Cells; 1977; 18(2):457-61. PubMed ID: 917834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combination chemotherapy (MOPP) in 60 patients with Hodgkin's disease (five years results) (author's transl)].
    Lauria F; Baccarani M; Barbieri E; Fiacchini M; Gobbi M; Tura S; Baccarani M
    Haematologica; 1975 Mar; 60(1):73-84. PubMed ID: 806500
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hodgkin's disease in children: long-term therapeutic results (author's transl)].
    Cramer P; Schaison G; Andrieu JM; Boiron M; Bernard J
    Bull Cancer; 1981; 68(5):456-64. PubMed ID: 6800427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Polychemotherapy of Hodgkin's disease (author's transl)].
    Jacquillat CL; Weil M; Auclerc G; Delbrück H; Chastang CL; Chelloul N; Boiron M; Bernard J
    Dtsch Med Wochenschr; 1975 Apr; 100(15):785-90. PubMed ID: 1122828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Results of combined chemotherapy (MOPP) in the treatment of patients with generalized Hodgkin's disease].
    Aghai E; Kende G; Many A; Ramot B
    Harefuah; 1974 Apr; 86(7):348-51. PubMed ID: 4846045
    [No Abstract]   [Full Text] [Related]  

  • 11. [Post-MOPP chemotherapy of Hodgkin's disease (author's transl)].
    Osieka R; Bruntsch U; Gallmeier WM; Seeber S; Schmidt CG
    Dtsch Med Wochenschr; 1976 Aug; 101(32):1177-82. PubMed ID: 59661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Possibilities of treatment of reduction in Hodgkin's disease. III. Can polychemotherapy when combined with radiotherapy of localised stages be reduced? (author's transl)].
    Teillet F; Delbrück H; Bayle-Weisgerber C; Asselain B; Lelièvre P; Bernard J
    Dtsch Med Wochenschr; 1981 May; 106(18):566-70. PubMed ID: 7215184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hodgkin's disease in childhood: long term results].
    Cramer P; Schaison G; Andrieu JM; Boiron M; Bernard J
    Arch Fr Pediatr; 1982 Apr; 39(4):223-9. PubMed ID: 6896975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hodgkin's disease: treatment of clinical stages II3+A, IB, IIB, IIIA and IIIB with short chemotherapy (3 MOPP, or 3 CVPP), splenectomy and limited irradiation. Results after 4 years of a prospective protocol including 94 patients].
    Andrieu JM; Casassus P; Coscas Y; Darmont J; Goubeau C; Katz M; Jacquillat C; Tricot G; Weil M
    Bull Cancer; 1982; 69(4):321-9. PubMed ID: 6897520
    [No Abstract]   [Full Text] [Related]  

  • 15. Combined modality therapy in previously untreated patients with advanced Hodgkin's disease: A 24-year follow-up study.
    Salloum E; Doria R; Farber LR; Roberts KB; Cooper DL
    Cancer J Sci Am; 1995; 1(4):267-73. PubMed ID: 9166487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The results of radiotherapy managements in Hodgkin's disease (author's transl)].
    Duchamp C; Clément R; Juin P
    J Radiol Electrol Med Nucl; 1977 May; 58(5):335-42. PubMed ID: 886527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of combined chemotherapy on the prognosis of Hodgkin's disease: retrospective study of 74 cases from 1959-1973].
    Walser A; Alberto P
    Schweiz Med Wochenschr; 1977 Apr; 107(16):569-77. PubMed ID: 67638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
    Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
    Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
    Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
    Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination chemotherapy plus low-dose involved-field radiotherapy for early clinical stage Hodgkin's lymphoma.
    Vassilakopoulos TP; Angelopoulou MK; Siakantaris MP; Kontopidou FN; Dimopoulou MN; Kokoris SI; Kyrtsonis MC; Tsaftaridis P; Karkantaris C; Anargyrou K; Boutsis DE; Variamis E; Michalopoulos T; Boussiotis VA; Panayiotidis P; Papavassiliou C; Pangalis GA
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):765-81. PubMed ID: 15183480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.